Kanika Sood

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

Melbourne’s Celleo, a start-up specialising in automated production systems for cell therapies for cancer, has mandated stockbroker Alpine Capital to raise $5 million in a private fund-raising round. A cervical cancer cell.   Loading...

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

There are signs of life at digital infrastructure business Campana, one of 2024’s IPO hopefuls that piggybacked off exploding demand for data centres. Street Talk reported in October that Campana, which operates fibre and cables connecting Asian data centres to clients, told fund managers timing for its $400 million-plus backdoor listing had been pushed back by a couple of months. Loading...

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

Distressed debt giant Oaktree Capital Management has discussed financing British-Indian industrialist Sanjeev Gupta’s Tahmoor coal mine in NSW – a sprawling operation that had fed the Whyalla and Port Kembla steelworks before being idled in early February amid financing troubles.

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

It hasn’t taken long for Celeste Funds Management portfolio manager Martin Byers to land a new role. Celeste portfolio manager Martin Byers is set to enter MA’s Brookfield Place office. BloombergLoading...

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

The $12.7 billion diagnostics giant Sonic Healthcare is set to lift its stake in biotech Microba Life Sciences to 19.9 per cent, the maximum permissible shareholding allowed in a listed company in absence of a takeover bid, as part of an equity raising. Microba Life Sciences chairman Ian Frazer, CEO Luke Reid and co-founder Gene Tyson at the listing ceremony in April 2022. Loading...